Clinical Trial Update: GIP/GLP-1RA as Adjunctive to Automated Insulin Delivery in Adults With Type 1 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a GIP/GLP-1 receptor agonist combination as an adjunct to automated insulin delivery in adults with Type 1 diabetes mellitus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• GIP/GLP-1 receptor agonist combination (GIP/GLP-1 receptor agonist)

Snippet

Sponsor: University of Bern | Conditions: Type 1 Diabetes (T1D) | Phase 3 | Status: RECRUITING